02Aug
FDA Issues Cannabidiol Marketing Warning as Congressional Pressure for Action Continues
Following through with its promise to take enforcement actions against companies marketing cannabis-derived products that could put consumers at risk, the Food and Drug Administration (FDA) recently issued a warning letter to Curaleaf Inc., a...
By:
Wilson Sonsini Goodrich & Rosati
Source Url: https://www.jdsupra.com/legalnews/fda-issues-cannabidiol-marketing-88358/
Related
Amendments to the federal laws - - Federal Law No. 150-FZ On Amendments to the - Federal Law On C...
Read More >
In the November 2019 election Virginia gained a Democratic “trifecta”—both legislative chambers a...
Read More >
A recent trend in U.S. employment law has been the adoption of stricter and stricter tests for when ...
Read More >
The DC Council has proposed legislation that would dramatically increase developers’ exposure for c...
Read More >
Welcome to your weekly update from the Allen & Overy Pensions team, bringing you up to speed on the ...
Read More >
Gig economy businesses across the country looked to what happened in California this year and cringe...
Read More >